Equator Beverage (MOJO) 10-Q 20 Jul 22 2022 Q2 Quarterly report Financial data

Cover

Cover - shares	6 Months Ended
	Jun. 30, 2022	Jul. 20, 2022
Cover [Abstract]
Document Type	10-Q
Amendment Flag	false
Document Quarterly Report	true
Document Transition Report	false
Document Period End Date	Jun. 30, 2022
Document Fiscal Period Focus	Q2
Document Fiscal Year Focus	2022
Current Fiscal Year End Date	--12-31
Entity File Number	000-55269
Entity Registrant Name	EQUATOR Beverage Company
Entity Central Index Key	0001414953
Entity Tax Identification Number	26-0884348
Entity Incorporation, State or Country Code	DE
Entity Address, Address Line One	185 Hudson Street
Entity Address, Address Line Two	Floor 25
Entity Address, City or Town	Jersey City
Entity Address, State or Province	NJ
Entity Address, Postal Zip Code	07302
City Area Code	929
Local Phone Number	264 7944
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		15,678,502

Condensed Balance Sheets (Unaud

Condensed Balance Sheets (Unaudited) - USD ($)	Jun. 30, 2022	Dec. 31, 2021
CURRENT ASSETS:
Cash and cash equivalents	$ 3,725	$ 46,481
Accounts receivable, net	166,740	108,635
Inventory	328,811	234,566
Supplier deposits	28,000	28,000
Prepaid expenses	14,456	11,702
Security deposit	113	113
Total Current Assets	541,845	429,497
CURRENT LIABILITIES:
Accounts payable and accrued expenses	116,165	58,944
Related party loans	225,000
SBA Loans
Total Current Liabilities	341,165	58,944
STOCKHOLDERS’ EQUITY
Common stock, 20,000,000 shares authorized at $0.001 par value, 15,678,502 and 15,548,790 shares issued and outstanding, at June 30, 2022 and December 31, 2021, respectively	15,679	15,549
Additional paid-in capital	23,713,652	23,745,449
Accumulated deficit	(23,528,651)	(23,390,445)
Total Stockholders’ Equity	200,680	370,553
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY	$ 541,845	$ 429,497

Condensed Balance Sheets (Una_2

Condensed Balance Sheets (Unaudited) (Parenthetical) - $ / shares	Jun. 30, 2022	Dec. 31, 2021
Statement of Financial Position [Abstract]
Common stock, shares authorized	20,000,000	20,000,000
Common stock, par value	$ 0.001	$ 0.001
Common stock, shares issued	15,678,502	15,548,790
Common stock, shares outstanding	15,678,502	15,548,790

Condensed Statements of Operati

Condensed Statements of Operations (Unaudited) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021
Income Statement [Abstract]
Revenue	$ 541,102	$ 614,279	$ 920,759	$ 1,018,045
Cost of Revenue	352,759	329,567	585,343	537,968
Gross Profit	188,343	284,712	335,416	480,077
Operating Expenses
Selling, general and administrative	188,230	203,540	469,796	421,770
(Loss)/Income from Operations	113	81,172	(134,380)	58,307
Other (Expense)/ Income	(2,940)		(3,826)	35,508
(Loss)/ Income Before Provision for Income Taxes	(2,827)	81,172	(138,206)	93,815
Benefit/(Provision) for Income Taxes
Net Income/(Loss)	$ (2,827)	$ 81,172	$ (138,206)	$ 93,815
Net Income/(Loss) per common share, basic and diluted	$ 0	$ 0.01	$ (0.01)	$ 0.01
Weighted average number of common shares outstanding, basic and diluted	15,810,725	15,680,809	15,658,344	15,494,002

Condensed Statements of Cash Fl

Condensed Statements of Cash Flows (Unaudited) - USD ($)	6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021
Cash flows from operating activities:
Net income/(loss)	$ (138,206)	$ 93,815
Adjustments to reconcile net loss to net cash used in operating activities:
Stock issued to directors and employees	136,073	110,470
SBA Loan Forgiveness		(35,508)
Changes in assets and liabilities:
Increase in accounts receivable	(58,105)	(145,672)
Increase in inventory	(94,245)	(172,174)
Increase in supplier deposits
(Increase)/Decrease in prepaid expenses and security deposit	(2,754)	8,447
Increase in accounts payable and accrued expenses	57,221	97,743
Increase in accrued payroll to officers
Net cash used in operating activities	(100,016)	(42,879)
Net cash provided by/ (used in) financing activities:
Proceeds from related party loan	352,000
Repayments of from related party loan	(127,000)
Proceeds from options exercise	25,448
Shares repurchased for cancellation	(193,188)
Net cash provided by financing activities	57,260
Net decrease in cash and cash equivalents	(42,756)	(42,879)
Cash and cash equivalents at beginning of period	46,481	50,233
Cash and cash equivalents at end of periods	$ 3,725	$ 7,354

Condensed Statements of Cash _2

Condensed Statements of Cash Flows (Unaudited) (Parenthetical)	6 Months Ended
	Jun. 30, 2022 USD ($) shares
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]
Stock issued to directors and officers, shares | shares	960,054
Director And Officer [Member]
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]
Stock issued to directors and officers, value | $	$ 161,521

Condensed Statements of Changes

Condensed Statements of Changes in Stockholders' Equity (Unaudited) - USD ($)	Common Stock [Member]	Additional Paid-in Capital [Member]	Accumulated Deficit [Member]	Total
Beginning balance, value at Dec. 31, 2020	$ 15,305	$ 23,644,945	$ (23,430,337)	$ 249,913
Begining balance, shares at Dec. 31, 2020	15,305,120
Stock issued to Directors and employees	$ 147	50,028		50,175
Stock issued to Directors and employees, shares	147,375
Net income			12,643	12,643
Ending balance, value at Mar. 31, 2021	$ 15,452	23,714,973	(23,417,694)	312,731
Ending balance, shares at Mar. 31, 2021	15,452,495
Beginning balance, value at Dec. 31, 2020	$ 15,305	23,644,945	(23,430,337)	249,913
Begining balance, shares at Dec. 31, 2020	15,305,120
Net income				93,815
Ending balance, value at Jun. 30, 2021	$ 15,639	23,775,081	(23,336,522)	454,198
Ending balance, shares at Jun. 30, 2021	15,639,453
Beginning balance, value at Dec. 31, 2020	$ 15,305	23,644,945	(23,430,337)	249,913
Begining balance, shares at Dec. 31, 2020	15,305,120
Ending balance, value at Dec. 31, 2021	$ 15,549	23,745,449	(23,390,445)	370,553
Ending balance, shares at Dec. 31, 2021	15,548,790
Beginning balance, value at Mar. 31, 2021	$ 15,452	23,714,973	(23,417,694)	312,731
Begining balance, shares at Mar. 31, 2021	15,452,495
Stock issued to Directors and employees	$ 187	60,108		60,295
Stock issued to Directors and employees, shares	186,958
Net income			81,172	81,172
Ending balance, value at Jun. 30, 2021	$ 15,639	23,775,081	(23,336,522)	454,198
Ending balance, shares at Jun. 30, 2021	15,639,453
Beginning balance, value at Dec. 31, 2021	$ 15,549	23,745,449	(23,390,445)	370,553
Begining balance, shares at Dec. 31, 2021	15,548,790
Stock issued to Directors and employees	$ 682	111,323		112,005
Stock repurchased and returned to Treasury	$ (375)	(100,875)		(101,250)
Stock repurchased and returned to Treasury, shares	(375,000)
Net income			(135,379)	(135,379)
Stock repurchased and returned to Treasury, shares	375,000
Ending balance, value at Mar. 31, 2022	$ 15,856	23,755,897	(23,525,824)	245,929
Ending balance, shares at Mar. 31, 2022	15,855,540
Beginning balance, value at Dec. 31, 2021	$ 15,549	23,745,449	(23,390,445)	$ 370,553
Begining balance, shares at Dec. 31, 2021	15,548,790
Stock issued to Directors and employees, shares	681,750			960,054
Stock repurchased and returned to Treasury, shares	455,342
Net income				$ (138,206)
Exercise of stock options, shares	159,054
Stock repurchased and returned to Treasury, shares	(455,342)
Ending balance, value at Jun. 30, 2022	$ 15,679	23,713,652	(23,528,651)	200,680
Ending balance, shares at Jun. 30, 2022	15,678,502
Beginning balance, value at Mar. 31, 2022	$ 15,856	23,755,897	(23,525,824)	245,929
Begining balance, shares at Mar. 31, 2022	15,855,540
Stock issued to Directors and employees	$ 119	23,949		24,068
Stock issued to Directors and employees, shares	119,250
Stock repurchased and returned to Treasury	$ (455)	(91,483)		(91,938)
Net income			(2,827)	(2,827)
Exercise of stock options	159	25,289		25,448
Ending balance, value at Jun. 30, 2022	$ 15,679	$ 23,713,652	$ (23,528,651)	$ 200,680
Ending balance, shares at Jun. 30, 2022	15,678,502

BUSINESS

BUSINESS	6 Months Ended
	Jun. 30, 2022
Accounting Policies [Abstract]
BUSINESS	NOTE 1 – BUSINESS Overview EQUATOR Beverage Company (formerly MOJO Organics, Inc.) (“MOJO”) is a Delaware corporation headquartered in Jersey City, NJ. The Company’s business is new product development, beverage production, marketing, distribution and the sale of beverages that are, Non-GMO Project verified, and USDA Organic. The Company’s flagship product is MOJO Coconut Water. In addition to Coconut Water, the Company produces Sparkling Coconut Water, Coconut Water + Mango Juice and Coconut Water + Pineapple Juice and USDA Organic Coconut Water. We seek to grow the market share of our products by expanding our hybrid distribution network through the relationships and efforts of our management, third party partners and our broker network, and add new products and packaging including pH7 water (pH is a scale of acidity) and energy beverages which are the two largest sectors of the beverage industry. The Company packages its beverages in 100% recyclable, Eco-Friendly packaging. The packaging has a low impact on the environment when recycled. CURRENT OPERATIONS Sales and Distribution The Company’s flagship product is MOJO Coconut Water. In addition to Coconut Water, the Company produces Sparkling Coconut Water, Coconut Water + Mango Juice, Coconut Water + Pineapple Juice, and Organic Coconut Water. We seek to grow the market share of our products by expanding our hybrid distribution network through the relationships and efforts of our management and third-party partners and broker network, and new products and packaging. The company packages its beverages in 100% recyclable, Eco-Friendly packaging that can be recycled infinite times and is not made from carbon oil-based packaging. The packaging has a very low impact on the environment, and does not contribute to landfills and the pollution of our bodies of water. Production The Company has multiple sources for its production. The Company’s fruit sources are of high quality. The fruit is part of the overall taste and quality of our products. Currently, the Company has multiple production facilities that it could source products from, each of the facilities could supply our forecasted demand. Competition The beverage industry is competitive. Competitors in our market compete for brand recognition, ingredient sourcing, product shelf space, and e-commerce page rankings. Our competitors have similar distribution channels and retailers to deliver and sell their products. Government Regulation Within the United States, beverages are governed by the U.S. Food and Drug Administration (the “FDA”). As such, it is necessary for the Company to establish, maintain and make available for inspection records as well as to develop labels (including nutrition information) that meet FDA requirements. The Company’s production facilities are subject to FDA regulation. Employees As of June 30, 2022, the Company had two employees. The Company also uses the services of contractors, consultants and other third-parties. We contract with food brokers to represent our products to specific specialized sales channels. We utilize the services of direct sales and distribution companies that deliver and sell our products to their customers. We contract with manufacturing facilities to produce our products and outsource the storage and transportation of our products. CORPORATE HISTORY AND DEVELOPMENT The Company was incorporated in 2007 and began producing MOJO branded products in 2016. EQUATOR Beverage Company (formerly MOJO Organics Inc) is headquartered in Jersey City, New Jersey and our internet site is www.EquatorBeverage.com. EQUATOR’s stock is traded on the OTC Markets under the symbol MOJO. On June 8, 2022, the Board of Directors and majority stockholder of the Company approved a change of name from MOJO Organics, Inc. to EQUATOR Beverage Company. This change of name was filed with the State of Delaware and became effective July 5, 2022. Interim Financial Statements The accompanying unaudited interim condensed financial statements have been prepared pursuant to the rules and regulations for reporting on Form 10-Q and article 10 of Regulation S-X and the related rules and regulations of the Securities and Exchange Commission (“SEC”). Accordingly, certain information and disclosures required by accounting principles generally accepted in the United States of America (“GAAP”) for complete financial statements have been condensed or omitted pursuant to such rules and regulations. However, the Company believes that the disclosures included in these financial statements are adequate to make the information presented not misleading. The unaudited interim condensed financial statements included in this document have been prepared on the same basis as the annual audited financial statements, and in the Company’s opinion, reflect all adjustments necessary for a fair presentation in accordance with GAAP and SEC regulations for interim financial statements. The results for the three and six months ended June 30, 2022 are not necessarily indicative of the results that the Company will have for any subsequent period. These unaudited condensed financial statements should be read in conjunction with the audited financial statements and the notes to those statements for the year ended December 31, 2021 included in the Company’s Annual Report on Form 10-K.

SUMMARY OF SIGNIFICANT ACCOUNTI

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	6 Months Ended
	Jun. 30, 2022
Accounting Policies [Abstract]
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Use of Estimates The financial statements are prepared in conformity with accounting principles generally accepted in the United States (“GAAP”). Management is required to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates. Cash and Cash Equivalents Cash equivalents include investment instruments and time deposits purchased with a maturity of three months or less. As of June 30, 2022, and June 30, 2021, the Company did no Accounts Receivable Accounts receivable are stated at the amount management expects to collect from outstanding balances. The Company provides for probable uncollectible amounts based upon its assessment of the current status of the individual receivables and after using reasonable collection efforts. The allowance for doubtful accounts as of June 30, 2022 and 2021 was zero Inventory Inventory, consisting solely of finished goods, are stated at the lower of cost (first-in, first-out method) or net realizable value (“NRV”). If necessary, the Company provides allowances to adjust the carrying value of its inventories to NRV when NRV is below cost. There were no such adjustments in 2022 or 2021. Revenue Recognition Revenue from sales of products is recognized when the related performance obligation is satisfied. The Company’s performance obligation is satisfied upon the shipment or delivery of products to customers. The Company’s products are sold on cash and credit terms which are established in accordance with standardized industry practices and typically require payment within 30 days of delivery. Costs incurred for sales incentives and discounts are accounted for as reductions in revenue. Deductions from Revenue Costs incurred for sales incentives and discounts are accounted for as reductions in revenue. These costs include payments to customers for performing merchandising activities on our behalf, including in store displays, promotions for new items and obtaining optimum shelf space. Shipping and Handling Costs Shipping and Handling Costs incurred to move finished goods from our distribution center to customer locations are included in the line Selling, General and Administrative Expenses in our Statements of Operations. Net Income/(Loss) Per Common Share The Company computes per share amounts in accordance with Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 260, “ There are no Income Taxes The Net Operating Loss Carryforwards for federal taxes was $ 3,748,885 , at June 30, 2022 and $ 3,748,885 for the State of New Jersey. The Deferred Tax Assets for federal taxes was $ 787,266 at June 30, 2022 and $ 337,400 for the State of New Jersey. The total Deferred Tax Assets was $ 1,124,666 at June 30, 2022. The Deferred Tax assets have been fully reserved by valuation allowances beyond that portion which is expected to offset current taxes. As of June 30, 2022, the Company’s Federal income tax payable and State Income Tax payable is zero . The Company provides for income taxes using the asset and liability approach in accounting for income taxes. Deferred tax assets and liabilities are recorded based on the differences between the financial statement and tax bases of assets and liabilities and the tax rates in effect when these differences are expected to reverse. Deferred tax assets are reduced by a valuation allowance if, based on the weight of available evidence, it is more likely than not that some or all of the deferred tax assets will not be realized. The Company did no As of June 30, 2022, and June 30, 2021, the Company had no SCHEDULE OF DEFERRED TAX ASSETS Tax Rate 2022 2021 Deferred Tax Asset as Tax Rate 2022 2021 Federal 21 % $ 787,266 $ 783,269 State of New Jersey 9 % $ 337,400 $ 335,687 Total $ 1,124,666 $ 1,118,956 Fair value of financial instruments The carrying amounts of financial instruments, which include cash, accounts receivable, accounts payable and accrued expense, approximate their fair values due to their short-term nature.

COMMITMENTS AND CONTINGENCIES

COMMITMENTS AND CONTINGENCIES	6 Months Ended
	Jun. 30, 2022
Commitments and Contingencies Disclosure [Abstract]
COMMITMENTS AND CONTINGENCIES	NOTE 3 – COMMITMENTS AND CONTINGENCIES Employment Agreements Pursuant to the Amended and Restated Employment Agreement (“the Agreement”) dated April 6, 2017 date, Mr. Simpson is paid a salary of $ 5,000 67,000 44,400 200,000 The term of the Agreement is through April 1, 2025. In the event that the Agreement is terminated for good reason, the Company shall pay Mr. Simpson any accrued but unpaid salary for services rendered to the date of termination, and an amount equal to the salary at the time of termination, payable for the remainder of the current term. As of June 30, 2022, there are 33 months remaining on the Agreement. The Company’s liability on the remainder of the Agreement is $ 165,000 2,211,000 During the six months ended June 30, 2022, Mr. Simpson was issued 402,000

STOCKHOLDERS_ EQUITY

STOCKHOLDERS’ EQUITY	6 Months Ended
	Jun. 30, 2022
Equity [Abstract]
STOCKHOLDERS’ EQUITY	NOTE 4 – STOCKHOLDERS’ EQUITY In June 2021, the Company decreased its Authorized Shares from 190,000,000 40,000,000 150,000,000 15,678,502 On June 8, 2022, the Board of Directors of the Company approved a prospective amendment to the Fourth Article of the Company’s Articles of Incorporation to decrease the authorized common stock from 40,000,000 0.001 20,000,000 0.001 effect a 1-for-2 reverse split of the Company’s Common Stock. Restricted Stock Issuances During the six months ended June 30, 2022, 801,000 On June 1, 2022, Mr. Simpson exercised his options to purchase 159,054 shares of Restricted and Non-Trading shares at $ 0.08 per share. The total exercise value was $ 25,449 On February 4, 2022, the board of Directors approved the issuance of 525,000 350,000 87,500 Additionally, Mr. Simpson was issued 201,000 37,500 37,500 Stock Purchased for Cancellation During the six months ended June 30, 2022 the Company purchased 830,342 193,187 During the year ended December 31, 2021 the Company purchased 382,913 765,826

STOCK OPTIONS

STOCK OPTIONS	6 Months Ended
	Jun. 30, 2022
Equity [Abstract]
STOCK OPTIONS	NOTE 5 – STOCK OPTIONS On June 1, 2022, Mr. Simpson exercised options to purchase 159,054 shares of Restricted and Non-Trading shares at $ 0.16 per share. The total exercise value was $ 25,449 . On February 4, 2022, the Company adjusted the exercise price of the options granted to Mr. Simpson from $ 0.32 per share to $ 0.16 On September 24, 2021, the Company extended the expiration date of the options granted to Mr. Simpson from April 6, 2022 to April 6, 2024 During the year ended December 31, 2021, Mr. Simpson exercised options to purchase 93,750 0.32 30,000 0 The following table summarizes stock option activity: SCHEDULE OF STOCK OPTIONS ACTIVITY Issued To Expiration Date Days to Expiration Exercise Price Options Outstanding, December 31, 2021 Glenn Simpson 4/6/2024 827 $ 0.16 159,054 Exercised, June 1, 2022 Glenn Simpson 4/6/2024 $ 0.16 (159,054 ) Outstanding, June 30, 2022 Glenn Simpson 4/6/2024 $ 0.16 - During the six months ended June 30, 2022 and 2021, compensation expense related to stock options was $ 0 no

RELATED PARTY TRANSACTIONS

RELATED PARTY TRANSACTIONS	6 Months Ended
	Jun. 30, 2022
Related Party Transactions [Abstract]
RELATED PARTY TRANSACTIONS	NOTE 6 – RELATED PARTY TRANSACTIONS During the six months ended June 30, 2022, Mr. Simpson lent $ 352,000 225,000 On June 1, 2022, Mr. Simpson exercised 159,054 stock options at an exercise price of $ 0.16 . The Company issued 159,054 Restricted and Non-Trading shares of Common Stock in exchange for the total exercise price of $ 25,449 During the year ended December 31, 2021, Mr. Simpson exercised 93,750 0.32 93,750 30,000

SBA LOANS _CARES ACT_

SBA LOANS “CARES ACT”	6 Months Ended
	Jun. 30, 2022
Debt Disclosure [Abstract]
SBA LOANS “CARES ACT”	NOTE 7 – SBA LOANS “CARES ACT” In January 2021, the Company received the loan forgiveness decision from the SBA for the loan proceeds under the Paycheck Protection Program. The full amount of the loan amounting $ 35,508

SUBSEQUENT EVENTS

SUBSEQUENT EVENTS	6 Months Ended
	Jun. 30, 2022
Subsequent Events [Abstract]
SUBSEQUENT EVENTS	NOTE 8 – SUBSEQUENT EVENTS On July 19, 2022, FINRA approved the 1-for-2 reverse split and the decrease in Authorized shares from 40,000,000 20,000,000 On July 5, 2022, the State of Delaware approved the Company’s name change to EQUATOR Beverage Company.

SUMMARY OF SIGNIFICANT ACCOUN_2

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)	6 Months Ended
	Jun. 30, 2022
Accounting Policies [Abstract]
Use of Estimates	Use of Estimates The financial statements are prepared in conformity with accounting principles generally accepted in the United States (“GAAP”). Management is required to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates.
Cash and Cash Equivalents	Cash and Cash Equivalents Cash equivalents include investment instruments and time deposits purchased with a maturity of three months or less. As of June 30, 2022, and June 30, 2021, the Company did no
Accounts Receivable	Accounts Receivable Accounts receivable are stated at the amount management expects to collect from outstanding balances. The Company provides for probable uncollectible amounts based upon its assessment of the current status of the individual receivables and after using reasonable collection efforts. The allowance for doubtful accounts as of June 30, 2022 and 2021 was zero
Inventory	Inventory Inventory, consisting solely of finished goods, are stated at the lower of cost (first-in, first-out method) or net realizable value (“NRV”). If necessary, the Company provides allowances to adjust the carrying value of its inventories to NRV when NRV is below cost. There were no such adjustments in 2022 or 2021.
Revenue Recognition	Revenue Recognition Revenue from sales of products is recognized when the related performance obligation is satisfied. The Company’s performance obligation is satisfied upon the shipment or delivery of products to customers. The Company’s products are sold on cash and credit terms which are established in accordance with standardized industry practices and typically require payment within 30 days of delivery. Costs incurred for sales incentives and discounts are accounted for as reductions in revenue.
Deductions from Revenue	Deductions from Revenue Costs incurred for sales incentives and discounts are accounted for as reductions in revenue. These costs include payments to customers for performing merchandising activities on our behalf, including in store displays, promotions for new items and obtaining optimum shelf space.
Shipping and Handling Costs	Shipping and Handling Costs Shipping and Handling Costs incurred to move finished goods from our distribution center to customer locations are included in the line Selling, General and Administrative Expenses in our Statements of Operations.
Net Income/(Loss) Per Common Share	Net Income/(Loss) Per Common Share The Company computes per share amounts in accordance with Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 260, “ There are no
Income Taxes	Income Taxes The Net Operating Loss Carryforwards for federal taxes was $ 3,748,885 , at June 30, 2022 and $ 3,748,885 for the State of New Jersey. The Deferred Tax Assets for federal taxes was $ 787,266 at June 30, 2022 and $ 337,400 for the State of New Jersey. The total Deferred Tax Assets was $ 1,124,666 at June 30, 2022. The Deferred Tax assets have been fully reserved by valuation allowances beyond that portion which is expected to offset current taxes. As of June 30, 2022, the Company’s Federal income tax payable and State Income Tax payable is zero . The Company provides for income taxes using the asset and liability approach in accounting for income taxes. Deferred tax assets and liabilities are recorded based on the differences between the financial statement and tax bases of assets and liabilities and the tax rates in effect when these differences are expected to reverse. Deferred tax assets are reduced by a valuation allowance if, based on the weight of available evidence, it is more likely than not that some or all of the deferred tax assets will not be realized. The Company did no As of June 30, 2022, and June 30, 2021, the Company had no SCHEDULE OF DEFERRED TAX ASSETS Tax Rate 2022 2021 Deferred Tax Asset as Tax Rate 2022 2021 Federal 21 % $ 787,266 $ 783,269 State of New Jersey 9 % $ 337,400 $ 335,687 Total $ 1,124,666 $ 1,118,956
Fair value of financial instruments	Fair value of financial instruments The carrying amounts of financial instruments, which include cash, accounts receivable, accounts payable and accrued expense, approximate their fair values due to their short-term nature.

SUMMARY OF SIGNIFICANT ACCOUN_3

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)	6 Months Ended
	Jun. 30, 2022
Accounting Policies [Abstract]
SCHEDULE OF DEFERRED TAX ASSETS	SCHEDULE OF DEFERRED TAX ASSETS Tax Rate 2022 2021 Deferred Tax Asset as Tax Rate 2022 2021 Federal 21 % $ 787,266 $ 783,269 State of New Jersey 9 % $ 337,400 $ 335,687 Total $ 1,124,666 $ 1,118,956

STOCK OPTIONS (Tables)

STOCK OPTIONS (Tables)	6 Months Ended
	Jun. 30, 2022
Equity [Abstract]
SCHEDULE OF STOCK OPTIONS ACTIVITY	The following table summarizes stock option activity: SCHEDULE OF STOCK OPTIONS ACTIVITY Issued To Expiration Date Days to Expiration Exercise Price Options Outstanding, December 31, 2021 Glenn Simpson 4/6/2024 827 $ 0.16 159,054 Exercised, June 1, 2022 Glenn Simpson 4/6/2024 $ 0.16 (159,054 ) Outstanding, June 30, 2022 Glenn Simpson 4/6/2024 $ 0.16 -

SCHEDULE OF DEFERRED TAX ASSETS

SCHEDULE OF DEFERRED TAX ASSETS (Details) - USD ($)	6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021
Operating Loss Carryforwards [Line Items]
Total	$ 1,124,666	$ 1,118,956
Domestic Tax Authority [Member]
Operating Loss Carryforwards [Line Items]
Total	$ 787,266	783,269
Tax rate	21%
State and Local Jurisdiction [Member]
Operating Loss Carryforwards [Line Items]
Total	$ 337,400	$ 335,687
Tax rate	9%

SUMMARY OF SIGNIFICANT ACCOUN_4

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) - USD ($)	6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021
Operating Loss Carryforwards [Line Items]
Cash equivalents	$ 0	$ 0
Allowance for doubtful accounts	$ 0	0
Antidilutive securities excluded computation, shares	0
Deferred tax assets	$ 1,124,666	1,118,956
Deferred tax liabilities	0	0
Accrued interest or penalties	0	0
Domestic Tax Authority [Member]
Operating Loss Carryforwards [Line Items]
Operating loss carryforwards for federal taxes	3,748,885
Deferred tax assets	787,266	783,269
State and Local Jurisdiction [Member]
Operating Loss Carryforwards [Line Items]
Operating loss carryforwards for federal taxes	3,748,885
Deferred tax assets	337,400	$ 335,687
Taxes Payable	$ 0

COMMITMENTS AND CONTINGENCIES (

COMMITMENTS AND CONTINGENCIES (Details Narrative) - USD ($)			6 Months Ended
	Feb. 04, 2022	Apr. 06, 2017	Jun. 30, 2022
Mr. Simpson [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Issuance of restricted and non-trading, shares	350,000		201,000
Issuance of restricted and non-trading, shares			402,000
Employment Agreements [Member] | Glenn Simpson [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Monthly salary		$ 5,000
Shares available for grant		67,000
Employee bonus		$ 44,400
Stock bonus, shares		200,000
Accrued salaries			$ 165,000
Employment Agreements [Member] | Glenn Simpson [Member] | Non Trading Restricted Common Stock [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Issuance of restricted and non-trading, shares			2,211,000

STOCKHOLDERS_ EQUITY (Details N

STOCKHOLDERS’ EQUITY (Details Narrative) - USD ($)				3 Months Ended		6 Months Ended	12 Months Ended
	Jun. 08, 2022	Jun. 01, 2022	Feb. 04, 2022	Jun. 30, 2022	Mar. 31, 2022	Jun. 30, 2022	Dec. 31, 2021	Jun. 30, 2021	May 30, 2021
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]
Common stock shares authorized				20,000,000		20,000,000	20,000,000	40,000,000	190,000,000
Reduction in common stock shares authorized								150,000,000
Common stock, shares outstanding				15,678,502		15,678,502	15,548,790
Common stock par value				$ 0.001		$ 0.001	$ 0.001
Reverse stock split	effect a 1-for-2 reverse split of the Company’s Common Stock.
Stock options exercised				$ 25,448
Stock repurchased during period value				$ 91,938	$ 101,250
Restricted Common Stock [Member]
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]
Stock repurchased during period shares						830,342
Stock repurchased during period value						$ 193,187
Board of Directors [Member]
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]
Common stock shares authorized	40,000,000
Common stock par value	$ 0.001
Issuance of restricted and non-trading, shares			525,000
Board of Directors [Member] | Minimum [Member]
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]
Common stock shares authorized	20,000,000
Common stock par value	$ 0.001
Director and Officers [Member] | Restricted and Non Trading Shares [Member]
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]
Issuance of restricted and non-trading, shares						801,000
Glenn Simpson [Member] | Restricted and Non Trading Shares [Member]
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period		159,054					93,750
Share price		$ 0.08
Stock options exercised		$ 25,449					$ 30,000
Mr. Simpson [Member]
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]
Issuance of restricted and non-trading, shares			350,000			201,000
Ms. Cudia [Member]
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]
Issuance of restricted and non-trading, shares			87,500			37,500
Mr.Devlin [Member]
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]
Issuance of restricted and non-trading, shares			87,500			37,500
Shareholders [Member]
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]
Stock repurchased during period shares							382,913
Stock repurchased during period value							$ 765,826

SCHEDULE OF STOCK OPTIONS ACTIV

SCHEDULE OF STOCK OPTIONS ACTIVITY (Details) - Glenn Simpson [Member] - $ / shares		6 Months Ended
	Sep. 24, 2021	Jun. 30, 2022
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]
Stock Options, Expiration Date	Apr. 06, 2024
Equity Option [Member]
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]
Stock Options, Expiration Date		Apr. 06, 2024
Stock Option, Outstanding, Days to Expiration		827 days
Stock Options, Outstanding, Exercise Price		$ 0.16
Stock Options, Outstanding Options		159,054
Stock Options, Exercisable, Exercise Price		$ 0.16
Stock Options, Exercised Options		(159,054)
Stock Options, Exercisable, Exercise Price		$ 0.16
Stock Options, Exercisable Options

STOCK OPTIONS (Details Narrativ

STOCK OPTIONS (Details Narrative) - USD ($)				3 Months Ended	6 Months Ended		12 Months Ended
	Jun. 01, 2022	Feb. 04, 2022	Sep. 24, 2021	Jun. 30, 2022	Jun. 30, 2022	Jun. 30, 2021	Dec. 31, 2021
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]
Stock issued during period shares stock options exercised, value				$ 25,448
Share-based compensation expense					$ 0	$ 0
Unrecognized compensation cost				$ 0	$ 0
Glenn Simpson [Member]
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]
Expiration date			Apr. 06, 2024
Glenn Simpson [Member] | Maximum [Member]
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]
Exercise price		$ 0.16
Glenn Simpson [Member] | Restricted and Non Trading Shares [Member]
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]
Stock issued during period shares stock options exercised	159,054						93,750
Exercise price	$ 0.16						$ 0.32
Stock issued during period shares stock options exercised, value	$ 25,449						$ 30,000
Accrued salaries							$ 0

RELATED PARTY TRANSACTIONS (Det

RELATED PARTY TRANSACTIONS (Details Narrative) - USD ($)		3 Months Ended	6 Months Ended		12 Months Ended
	Jun. 01, 2022	Jun. 30, 2022	Jun. 30, 2022	Jun. 30, 2021	Dec. 31, 2021
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]
Proceeds from related party debt			$ 352,000
Exercise of stock options		$ 25,448
Mr. Simpson [Member]
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]
Proceeds from related party debt			352,000
Loan payable		$ 225,000	$ 225,000
Glenn Simpson [Member] | Restricted and Non Trading Shares [Member]
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]
Stock issued during period shares stock options exercised	159,054				93,750
Exercise price	$ 0.16				$ 0.32
Exercise of stock options	$ 25,449				$ 30,000
Accrued payroll					$ 30,000

SBA LOANS _CARES ACT_ (Details

SBA LOANS “CARES ACT” (Details Narrative)	1 Months Ended
	Jan. 31, 2021 USD ($)
Paycheck Protection Program [Member]
Short-Term Debt [Line Items]
Debt forgiveness	$ 35,508

SUBSEQUENT EVENTS (Details Narr

SUBSEQUENT EVENTS (Details Narrative) - shares	Jul. 20, 2022	Jul. 19, 2022	Jun. 30, 2022	Dec. 31, 2021	Jun. 30, 2021	May 30, 2021
Subsequent Event [Line Items]
Common Stock, Shares Authorized			20,000,000	20,000,000	40,000,000	190,000,000
Subsequent Event [Member]
Subsequent Event [Line Items]
Common Stock, Shares Authorized	20,000,000	40,000,000